2021 International Symposium on Treatment of Brain and Neurology Disorders  | Web view
The brain is the most complex and mysterious organ in the human body. In the 21st century, when technology is advancing by leaps and bounds, the mystery of "brain science" has attracted countless scientists making all-out effort to decipher the code, analyze the mechanism of action, and deconstruct the brain in-depth in the hope of eliminating neurological brain diseases and creating human welfare.

To promote the breakthrough of brain technology and the R&D process innovation of neurological brain diseases, the Ministry of Science and Technology (MoST) has organized the "2021 International Symposium on Treatment of Brain and Neurology Disorders". In this event, global assembly of reputable researchers, medical KOLs, industrial parties including European biotechs and active Taiwanese tech investors facilitate the mutual advancement of the latest therapeutic progress of neurological brain disorders at a hybrid symposium for on-site and on-line audiences. In addition, the symposium will comprehensively gather remarkable R&D results and clinical applications to inspire brain technology development and create innovative business model through multidisciplinary integration.

In this international symposium, we will discuss:
Neurological Brain Diseases: clinical applications of mechanistic research, unsolved illness, and innovative therapies
Brainscience Business Opportunities: business models such as development trends, unmet medical needs, and collaboration & licensing
October 5, 2021 (Tuesday)

13:30 PM - 17:30 PM (GMT+8)
(13:00 Guest Reception)

GIS NTU Meeting Center –
Room Socrates

B1, No. 85, Sec. 4, Roosevelt Rd., Da’an Dist., Taipei City, Taiwan (R.O.C.)

  Time Agenda Speaker
13:00-13:30 Registration
13:30-13:35 Opening Remarks :
Bridge between Taiwanese and European Brain-Neuro science
Dr. Hong-Chen Chen 陳鴻震
Director, Department of Life Sciences, MoST
13:35-13:40 Photo Call
13:40-13:50 Innovative Brain :
Strategy for Brain Science Development in Taiwan
Dr. Julie Y.H. Chan 華瑜
Institute for Translational Research in Biomedicine, Cheng Gung Memorial Hospital
13:50-14:20 Keynote Speech :
How do Innovation Hubs in Europe Translate Their Ideas into Business, especially for CNS
GM : Dr. Henk Joos
Agio Capital & Business Solutions
14:20-14:50 Noninvasive Focused Ultrasound Induced CNS Intervention Dr. Hao-Li Liu 劉浩澧
Department of Electrical Engineering, National Taiwan University
14:50-15:20 Disease-modifying Treatments for Patients Suffering from Protein-misfolding Disorders Study Director : Dr. Sofie Carmans
Degeneration treatment company: reMYND NV
15:20-15:30 Coffee break

15:30-16:00 Decoding Brain and Genetic Signatures of Migraine Dr. Shih-Pin Chen M.D., PhD 陳世彬
Institute of Neuroscience, National Yang Ming Chiao Tung University
16:00-16:30 Potential Therapeutic Vaccines for Autoimmune Myasthenia Gravis CEO : Dr. Stéphane Huberty
M.D., Ph.D.

Therapeutic vaccine company: CuraVac, Inc.
16:30-17:00 Research on Intelligent Adaptive Deep Brain Stimulation System for Precise Treatment of Parkinson’s Disease Dr. Ming-Dou Ker 柯明道
Biomedical Electronics Translational Research Center (BETRC), National Yang Ming Chiao Tung University
17:00-17:30 Next-generation Medicines on Neuroprotection for Brain Diseases CSO: Dr. Pablo Villoslada
M.D., Ph.D.

CNS treatment company:
Accure Therapeutics
17:30 Closing
Copyright © 2021 臺灣腦科技發展及國際躍升計畫 All Rights Reserved.